Moxalactam: preclinical evaluation
Chabbert, Y.A.
La Semaine des Hopitaux Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(26): 1943-1946
1983
ISSN/ISBN: 0037-1777 PMID: 6310782 Document Number: 215796
Document emailed within 1 workday
Related Documents
Reed, M.D.; Bertino, J.S.; Aronoff, S.C.; Speck, W.T.; Blumer, J.L. 1982: Evaluation of moxalactam Clinical Pharmacy 1(2): 124-134McCracken, G.H.; Threlkeld, N.; Mize, S.; Baker, C.J.; Kaplan, S.L.; Faingezicht, I.; Feldman, W.E.; Schaad, U. 1984: Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. a prospective controlled evaluation JAMA 252(11): 1427-1432
Bazan, M.T.; Seale, N.S. 1982: A technique for immediate evaluation of preclinical exercises Journal of Dental Education 46(12): 726-728
Lavelle, F.; Bissery, M.C.; André, S.; Roquet, F.; Riou, J.F. 1996: Preclinical evaluation of CPT-11 and its active metabolite SN-38 Seminars in Oncology 23(1 Suppl 3: 11-20
Furukawa, T. 1996: Yawning behavior for preclinical drug evaluation Methods and Findings in Experimental and Clinical Pharmacology 18(2): 141-155
Hashimoto, K. 2003: Preclinical evaluation of drug induced QT prolongation Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 121(6): 408-410
Taetle, R.; Howell, S.B. 1983: Preclinical re-evaluation of benzaldehyde as a chemotherapeutic agent Cancer Treatment Reports 67(6): 561-566
Churin, A.A.; Karpova, G.V.; Fomina, T.I.; Vetoshkina, T.V.; Dubskaia, T.I.; Voronova, O.L.; Filimonov, V.D.; Belianin, M.L.; Usov, V.I. 2008: Preclinical toxicological evaluation of Pentamang and Mangascan Eksperimental'naia i Klinicheskaia Farmakologiia 71(4): 49-52
Kelner, M.J.; McMorris, T.C.; Beck, W.T.; Zamora, J.M.; Taetle, R. 1987: Preclinical evaluation of illudins as anticancer agents Cancer Research 47(12): 3186-3189
Wong, A.Y.; Watson, J.F.; Thye, R.P. 1979: Evaluation of predictor variables for a self-instructional preclinical course Journal of Dental Education 43(12): 637-640
Bardzinski, M.A.; Light, E.I.; Rakow, B.; Kuchmas, J. 1985: Evaluation of a Ag-In-Pd casting alloy for preclinical teaching Journal of Dental Education 49(8): 589-591
Vann, W.F.; Machen, J.B.; Hounshell, P.B. 1983: Effects of criteria and checklists on reliability in preclinical evaluation Journal of Dental Education 47(10): 671-675
Brehm, T.W. 1972: Peer evaluation of fixed partial dentures in a preclinical course Journal of Dental Education 36(2): 54-55
Edwards, W.S.; Morse, P.K.; Mitchell, R.J. 1982: A practical evaluation system for preclinical restorative dentistry Journal of Dental Education 46(12): 693-696
Osieka, R. 1984: Human malignant melanoma: preclinical and clinical drug evaluation Behring Institute Mitteilungen 74: 353-367
Ariyoshi, Y.; Ota, K. 1989: Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-2): 1379-1385
Syromiatnikov, I.P. 1998: Evaluation of preclinical signs due to exposure of workers to static magnetic fields Gigiena i Sanitariia 1: 14-15
Badet, L.; Abdennebi, H.B.; Petruzzo, P.; McGregor, B.; Espa, M.; Hadj-Aissa, A.; Ramella-Virieux, S.; Steghens, J.-P.; Portoghese, F.; Morelon, E.; Martin, X. 2005: Evaluation of IGL-1, a new organ preservation solution: preclinical results in renal transplantation Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 15(3): 481-488; Discussion 487
Yazdani, S.K.; Sheehy, A.; Nakano, M.; Nakazawa, G.; Vorpahl, M.; Otsuka, F.; Donn, R.S.; Perkins, L.E.; Simonton, C.A.; Kolodgie, F.D.; Virmani, R. 2013: Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents Journal of Invasive Cardiology 25(8): 383-390
Anderson, R.A.; Feathergill, K.A.; Diao, X-Hui.; Cooper, M.D.; Kirkpatrick, R.; Herold, B.C.; Doncel, G.F.; Chany, C.J.; Waller, D.P.; Rencher, W.F.; Zaneveld, L.J.D. 2002: Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent Journal of Andrology 23(3): 426-438